Spire Healthcare Group (LON:SPI – Get Free Report) released its quarterly earnings results on Wednesday. The company reported GBX (0.50) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Stock Performance
SPI traded up GBX 1 on Thursday, hitting GBX 247.50. 71,514,227 shares of the stock traded hands, compared to its average volume of 5,796,127. The business has a fifty day moving average price of GBX 238.06 and a two-hundred day moving average price of GBX 207.59. The company has a current ratio of 0.63, a quick ratio of 0.73 and a debt-to-equity ratio of 177.14. The firm has a market capitalization of £991.48 million, a PE ratio of 61.88, a P/E/G ratio of 1.06 and a beta of 0.93. Spire Healthcare Group has a 52 week low of GBX 140.80 and a 52 week high of GBX 249.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada downgraded shares of Spire Healthcare Group to a “sector perform” rating and dropped their target price for the stock from GBX 300 to GBX 250 in a report on Monday, September 7th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of GBX 247.50.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
See Also
- Five stocks we like better than Spire Healthcare Group
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
- First Watch’s Growth Story Meets a Reality Check
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
